Ascendis Pharma
Denmark, DK · 6 known investors
Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases. The company focuses on long-acting therapeutic formulations to address endocrine and rare disease indications.
Founders & leadership
JM
Jan Møller MikkelsenFounder, President and Chief Executive Officer
Investors · 6
In the news
- Dorsey Wright & Associates Acquires 3,375 Shares of Ascendis Pharma A/S $ASND - Daily Politicaldailypolitical.com · 2026
- BofA raises Ascendis Pharma stock price target on revenue outlook By Investing.cominvesting.com · 2026
- Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24%finance.yahoo.com · 2026
- Ascendis Pharma Closes Warrant Exercise Window, Expands Share Capital - TipRanks.comtipranks.com · 2026
- Ascendis Pharma details warrant exercises, capital boost | ASND SEC Filing - Form 6-Kstocktitan.net · 2026
- Ascendis Pharma jumps as investors weigh cash boost, pipeline momentum, and possible index-related buying | Quiver Quantitativequiverquant.com · 2026